| 000 | 00881 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250517232742.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a2199-1154 | ||
| 024 | 7 |
_a10.1007/s40801-018-0140-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAscher, John | |
| 245 | 0 | 0 |
_aPatient Understanding of the Neuropsychiatric Risks Associated with Branded Bupropion Hydrochloride Products Used for Smoking Cessation. _h[electronic resource] |
| 260 |
_bDrugs - real world outcomes _cSep 2018 |
||
| 300 |
_a181-191 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aStemhagen, Annette | |
| 700 | 1 | _aStender, Monika | |
| 700 | 1 | _aWin, Beta | |
| 700 | 1 | _aWinter, Christina | |
| 773 | 0 |
_tDrugs - real world outcomes _gvol. 5 _gno. 3 _gp. 181-191 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40801-018-0140-2 _zAvailable from publisher's website |
| 999 |
_c28727988 _d28727988 |
||